Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Chapple

Showing results (141-150 of 166) with videos related to

Pageof 17
Sort By:
European Urology|July 25, 2016
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysisMauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al.
The Journal of Urology|March 20, 2020
Reply by AuthorsSteven A Kaplan, Sender Herschorn, Kevin T McVary, et al.
The Journal of Urology|January 3, 2020
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)Steven A Kaplan, Sender Herschorn, Kevin T McVary, et al.
Neurourology and Urodynamics|September 4, 2013
Development of two electronic bladder diaries: a patient and healthcare professionals pilot studyAltaf Mangera, Alberto Marzo, Nicola Heron, et al.
European Urology|March 12, 2016
Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)Marcus J Drake, Christopher Chapple, Ahmet A Esen, et al.
European Urology Focus|July 16, 2023
Predicting Prostate Surgery Outcomes from Standard Clinical Assessments of Lower Urinary Tract Symptoms To Derive Prognostic Symptom and Flowmetry CriteriaHiroki Ito, Kentaro Sakamaki, Grace J Young, et al.
British Journal of Pharmacology|June 6, 2006
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderPaul Abrams, Karl-Erik Andersson, Jerry J Buccafusco, et al.
Neurourology and Urodynamics|February 13, 2014
Bladder function after radical hysterectomy for cervical cancerRosa M Laterza, Karl-Dietrich Sievert, Dirk de Ridder, et al.
BMC Medicine|March 25, 2017
Can incontinence be cured? A systematic review of cure ratesRob Riemsma, Suzanne Hagen, Ruth Kirschner-Hermanns, et al.
European Urology|June 6, 2018
Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)Christian Gratzke, Rob van Maanen, Christopher Chapple, et al.
Pageof 17

Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
European Urology|July 25, 2016
Male Lower Urinary Tract Symptoms and Cardiovascular Events: A Systematic Review and Meta-analysisMauro Gacci, Giovanni Corona, Arcangelo Sebastianelli, et al.
The Journal of Urology|March 20, 2020
Reply by AuthorsSteven A Kaplan, Sender Herschorn, Kevin T McVary, et al.
The Journal of Urology|January 3, 2020
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS)Steven A Kaplan, Sender Herschorn, Kevin T McVary, et al.
Neurourology and Urodynamics|September 4, 2013
Development of two electronic bladder diaries: a patient and healthcare professionals pilot studyAltaf Mangera, Alberto Marzo, Nicola Heron, et al.
European Urology|March 12, 2016
Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)Marcus J Drake, Christopher Chapple, Ahmet A Esen, et al.
European Urology Focus|July 16, 2023
Predicting Prostate Surgery Outcomes from Standard Clinical Assessments of Lower Urinary Tract Symptoms To Derive Prognostic Symptom and Flowmetry CriteriaHiroki Ito, Kentaro Sakamaki, Grace J Young, et al.
British Journal of Pharmacology|June 6, 2006
Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladderPaul Abrams, Karl-Erik Andersson, Jerry J Buccafusco, et al.
Neurourology and Urodynamics|February 13, 2014
Bladder function after radical hysterectomy for cervical cancerRosa M Laterza, Karl-Dietrich Sievert, Dirk de Ridder, et al.
BMC Medicine|March 25, 2017
Can incontinence be cured? A systematic review of cure ratesRob Riemsma, Suzanne Hagen, Ruth Kirschner-Hermanns, et al.
European Urology|June 6, 2018
Long-term Safety and Efficacy of Mirabegron and Solifenacin in Combination Compared with Monotherapy in Patients with Overactive Bladder: A Randomised, Multicentre Phase 3 Study (SYNERGY II)Christian Gratzke, Rob van Maanen, Christopher Chapple, et al.
Pageof 17